Butyrate, aspirin and colorectal cancer

European Journal of Cancer Prevention

Volumn 5, Issue 4, 1996, Pages 221-231

  Csordas, A ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Apoptosis; Aspirin; Butyrate; Colon cancer prevention; Colonocytes; Cyclo oxygenase 2; Histone acetylation; Intestinal epithelial cells

Indexed keywords

ACETYLSALICYLIC ACID; BUTYRIC ACID; CYCLOOXYGENASE 2; HISTONE DEACETYLASE;

APOPTOSIS; CANCER INHIBITION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; EPITHELIUM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACETYLATION; APOPTOSIS; ASPIRIN; BUTYRATES; CELL DIVISION; COLORECTAL NEOPLASMS; HUMANS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0029804064     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199608000-00002     Document Type: Review

References (68)

1. Antequera F, Boyes J, Bird A (1990). High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-14.
2. Arts J, Lansink M, Grimbergen J, Toet KH, Kooistra T (1995). Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and Trichostatin A in human endothelial cells involves histone acetylation. Biochem J 310: 171-6.
3. Bartram HP, Scheppach W, Schmid H et al (1993). Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia and pH. Cancer Res 53: 3283-8.
4. Bartram HP, Englert S, Scheppach W et al (1994). Antagonistic effects of deoxycholic acid and butyrate on epithelial cell proliferation in the proximal and distal human colon. J Gastroenterol 32: 389-92.
5. Boffa LC, Lupton JR, Mariani MR et al (1992). Modulation of colonic epithelial cell proliferation, histone acetylation and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906-12.
6. Bradbury EM (1992). Reversible histone modifications and the chromosome cell cycle. Bio Essays 14: 9-16.
7. Burkitt DP (1969). Related disease - related cause? Lancer ii: 1229-31.
8. Burkitt DP (1979). Don't Forget Fibre in Your Diet. Martin Dunitz, London.
9. Carroll KM, Wong TT, Drabik DL, Change EB (1988). Differentiation of rat small intestinal epithelial cells by extracellular matrix. Am J Physiol 254: G355-60.
10. Clarke AR, Purdie CA, Harrison DJ et al (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-52.
11. Clausen MR (1995). Butyrate and colorectal cancer in animals and humans. Eur J Cancer Prev 4: 483-90.
12. Cleave TL (1974). The Saccharine Diseases. Wright, Bristol.
13. Cousens LS, Gallwitz D, Alberts BM (1979). Different accessibilities in chromatin to histone acetylase. J Biol Chem 254: 1716-23.
14. Csordas A (1990). On the biological role of histone acetylation. Biochem J 265: 23-38.
15. Csordas A (1995). Toxicology of butyrate and short-chain fatty acids. In Role of Gut Bacteria in Human Toxicology and Pharmacology (ed Hill MJ); Taylor and Francis, London, pp. 105-27.
16. Cummings JH (1984). Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol 19: S93-99.
17. Cummings JH, Branch WJ (1986). Fermentation and the production of short-chain fatty acids in the human large intestine. In Dietary Fiber, Basic and Clinical Aspects (eds Vahouny GV, Kritchevsky D); Plenum Press, New York, pp. 131-49.
18. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, Macfarlane GT (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-7.
19. Desai TK, Nathan DF, Morin MJ (1993). Potentiation of butyrate-induced differentiation in human colon tumor cells by deoxycholate. Cancer Lett 69: 181-6.
20. Deschner EE, Ruperto JF, Lupton JR, Newmark HL (1990). Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis. Cancer Lett 52: 79-82.
21. DeWitt D, Smith WL (1995). Yes, but do they still get headaches? Cell 83: 345-8.
22. DuBois RN, Awad J, Morrow J, Roberts LJ, Bisop PR (1994). Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alfa and phorbol ester. J Clin Invest 93: 493-8.
23. Eberhart CE, Coffey RJ, Radhika A et al (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-8.
24. Freeman HJ (1986). Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology 91: 596-602.
25. Gibson PR, Moeller I, Kagelari O, Folino M, Young GP (1992). Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J Gastroenterol Hepatol 7: 165-72.
26. Giovannucci E, Egan KM, Hunter DJ et al (1995). Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-14.
27. Hague A, Paraskeva C (1995). The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur J Cancer Prev 4: 359-64.
28. Hague A, Manning AM, Hanlon KA et al (1993). Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55: 498-505.
29. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C (1994). BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 9: 3367-70.
30. Hague A, Elder D, Hicks DJ, Paraskeva C (1995). Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and the bile salt deoxycholate. Int J Cancer 60: 400-6.
31. Hanson PJ, Parsons DJ (1976). The utilization of glucose and production of lactate by in vitro preparations of rat small intestine: effects of vascular perfusion. J Physiol 255: 775-95.
32. Hill MJ (1995a). Role of Gut Bacteria in Human Toxicology and Pharmacology. Taylor and Francis, London.
33. Hill MJ (1995b). Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prev 4: 353-8.
34. Hill MJ (1995c). Introduction: dietary fibre, butyrate and colorectal cancer. Eur J Cancer Prev 4: 341-4.
35. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53.
36. Kargman SL, O'Neill GP, Vickers PJ et al (1995). Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-9.
37. Kashtan H, Tern HS, Jenkins DJA et al (1992). Colonic fermentation and markers of colorectal-cancer risk. Am J Clin Nutr 55: 723-8.
38. Kripke SA, Fox AD, Berman JM, Settle RG, Rombeau JL (1989). Stimulation of intestinal mucosal growth with intracolonic infusion of short chain fatty acids. J Parenter Enter Nutr 13: 109.
39. Kritchevsky D (1995). Epidemiology of fibre, resistant starch and colorectal cancer. Eur J Cancer Prev 4: 345-52.
40. Kruh J (1982). Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65-82.
41. Kruh J, Defer N, Tichonicky LL (1992). Action moléculaire et cellulaire du butyrate. C R Soc Biol 186: 12-25.
42. Langenbach R, Morham SG, Tiano HF et al (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced gastric ulceration. Cell 83: 483-92.
43. Levine A, Momand J, Finlay CA (1991). The p53 tumour suppressor gene. Nature 351: 453-6.
44. Lewis JD, Meehan RR, Henzel WJ et al (1992). Purification, sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-14.
45. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-9.
46. Lupton JR (1995). Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies. Eur J Cancer Prev 4: 373-8.
47. McIntyre A, Gibson PR, Young GP (1993). Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34: 386-91.
48. McDonald IA, Webb GR, Mahoney DE (1978). Fecal hydroxysteroid dehydrogenase activities in vegetarian Seventh Day Adventists, control subjects and bowel cancer patients. Am J Clin Nutr 31: S233-8.
49. Miyashita T, Yamamoto H, Nishimune Y et al (1994). Activation of the cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. FEBS Lett 353: 225-9.
50. Morham SG, Langenbach R, Loftin CD et al (1995). Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-82.
51. Reddy BS (1987). Dietary fiber and colon cancer: animal model studies. Prev Med 16: 559-65.
52. Roediger WEW (1982). Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424-9.
53. Rubenstein P, Sealy L, Marshall S, Chalkley R (1979). Cellular protein synthesis and inhibition of cell division are independent of butyrate-induced histone hyperacetylation. Nature 280: 692-3.
54. Sakata T (1987). Stimulatory effect of short chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fiber gut microbes and luminal trophic factors. Br J Nutr 58: 95-103.
55. Sakata T (1995). Effects of short-chain fatty acids on the proliferation of gut epithelial cells in vivo. In Physiological and Clinical Aspects of Short-Chain Fatty Acids (eds Cummings JH, Rombeau JL, Sakata T); Cambridge University Press, Cambridge, UK, pp. 289-305.
56. Sano H, Kawahito Y, Wilder RL et al (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-9.
57. Scheppach W (1994). Effects of short chain fatty acids on gut morphology and function. Gut 35 S1: S35-8.
58. Scheppach W, Fabian C, Sachs M, Kasper H (1988). The effect of starch malabsorption on fecal short-chain fatty acid excretion in man. Scand J Gastroenterol 23: 755-9.
59. Scheppach W, Bartram P, Richter A et al (1992). Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enter Nutr 16: 43-8.
60. Smith WL, DeWitt DL (1995). Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 15: 179-94.
61. Tamura T, Ishihara M, Lamphier MS et al (1995). An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-9.
62. Thornton JR (1981). High colonic pH promotes colorectal cancer. Lancet 1: 1081-3.
63. Tsujii M, DuBois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501.
64. Turner BM (1991). Histone acetylation and control of gene expression. J Cell Sci 99: 13-20.
65. Vernia P, Ciarniello P, Cittadini M et al (1989). Stool pH and SCFA in colorectal cancer and polyps. Gastroenterology 96: A528.
66. Walker ARP, Walker BF, Walker AJ (1986). Faecal pH, dietary fibre intake and proneness to colon cancer in four South African populations. Br J Cancer 53: 489-95.
67. Wolffe A (1994). Transcription: in tune with the histones. Cell 77: 13-16.
68. Yoshida M, Kijima M, Akita M, Beppu T (1990). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J Biol Chem 265: 17174-9.